United Kingdom, October 26, 2017: The European Medical Journal welcomes you to the 2017 edition of the EMJ Respiratory eJournal.

Spasmodic dysphonia (SD) was described in 1871 as ‘nervous hoarseness’, known as ‘spastic dysphonia’.1 It was not until 1976 that it was acknowledged as…

According to the World Health Organization (WHO), obesity is approaching pandemic levels. It has now been indisputably proven that obesity increases the…

Milan, Italy, a city renowned for its style and beauty, provided a splendid setting for the 27th ERS International Congress.

Pulmonary vascular remodelling is common in chronic lung disorders.1 Alterations in vascular and parenchymal structures may impair gas exchange in…

The symposium explored the use of state-of-the-art technologies in building the evidence for Alpha 1 Antitrypsin (AAT) efficacy, namely the use of…

Chronic obstructive pulmonary disease (COPD) is a progressive, irreversible condition, characterised by symptoms of breathlessness, cough, sputum…

The main objectives of the two symposia were to raise awareness of nontuberculous mycobacterial lung disease (NTM-LD); evaluate the key microbiological…

Chronic obstructive pulmonary disease (COPD), along with other respiratory problems, is accompanied by major cardiovascular comorbid conditions…